CD30 positive systemic anaplastic large cell lymphoma - brentuximab vedotin initial PBS authority application form (PB123)

This information was printed Tuesday 21 May 2019 from It may not include all of the relevant information on this topic. Please consider any relevant site notices at when using this material.

Page last updated: 13 February 2019